U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188011188011Vaccine Therapy in Treating Patients With Ovarian Epithelial or Primary Peritoneal CancerCompletedHas ResultsOvarian Cancer|Primary Peritoneal Cavity CancerBiological: incomplete Freund's adjuvant|Biological: ovarian cancer peptide vaccine|Biological: sargramostim|Biological: tetanus toxoid helper peptide|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00091273
188012188012CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic AmyloidosisActive, not recruitingNo Results AvailableMultiple Myeloma and Plasma Cell NeoplasmDrug: dexamethasone|Drug: lenalidomidehttps://ClinicalTrials.gov/show/NCT00091260
188013188013Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for CancerCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: tetracycline hydrochloride|Other: placebohttps://ClinicalTrials.gov/show/NCT00091247
188014188014Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid LeukemiaRecruitingNo Results AvailableLeukemiaDrug: gemtuzumab ozogamicinhttps://ClinicalTrials.gov/show/NCT00091234
188015188015Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity CancerTerminatedNo Results AvailablePrimary Peritoneal Cavity Cancer|Recurrent Ovarian Epithelial CancerDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00091195
188016188016Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNo Results AvailableChildhood Central Nervous System Germ Cell Tumor|Childhood Extragonadal Germ Cell Tumor|Childhood Hepatoblastoma|Childhood Hepatocellular Carcinoma|Childhood High-grade Cerebral Astrocytoma|Childhood Low-grade Cerebral Astrocytoma|Childhood Malignant OvarDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00091182
188017188017Levocarnitine in Treating Fatigue in Cancer PatientsCompletedNo Results AvailableFatigue|Unspecified Adult Solid Tumor, Protocol SpecificDietary Supplement: levocarnitine|Other: placebohttps://ClinicalTrials.gov/show/NCT00091169
188018188018Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerTerminatedNo Results AvailableLung CancerDrug: gefitinib|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00091156
188019188019Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: gp100 antigen|Biological: incomplete Freund's adjuvant|Biological: keyhole limpet hemocyanin|Drug: fludarabine phosphate|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00091143
188020188020SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical CellsCompletedNo Results AvailableAtypical Squamous Cells of Undetermined Significance|Cervical Cancer|High-grade Squamous Intraepithelial Lesion|Low-grade Squamous Intraepithelial LesionBiological: HspE7|Other: placebo|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00091130
188021188021Bortezomib in Treating Patients With Advanced Cancer and Liver DysfunctionCompletedNo Results AvailableHepatic Complications|Malignant NeoplasmDrug: bortezomib|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00091117
188022188022Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: MART-1:27-35 peptide vaccine|Biological: aldesleukin|Biological: filgrastim|Biological: incomplete Freund's adjuvant|Biological: therapeutic autologous lymphocytes|Biological: therapeutic tumor infiltrating lymphocytes|Drug: cyclophosphamide|Drug: fludarabine phosphate|Procedure: autologous hematopoietic stem cell transplantation|Procedure: in vitro-treated peripheral blood stem cell transplantation|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00091104
188023188023Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's LymphomaActive, not recruitingNo Results AvailableLong-term Effects Secondary to Cancer Therapy in Children|LymphomaOther: medical chart review|Other: questionnaire administration|Procedure: management of therapy complicationshttps://ClinicalTrials.gov/show/NCT00091091
188024188024Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By SurgeryTerminatedNo Results AvailableGastrointestinal Stromal TumorBiological: oblimersen sodium|Drug: imatinib mesylate|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00091078
188025188025Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: sargramostim|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00091052
188026188026Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With SurgeryCompletedNo Results AvailableLung CancerBiological: recombinant fowlpox GM-CSF vaccine adjuvant|Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine|Biological: recombinant vaccinia-CEA(6D)-TRICOM vaccine|Drug: carboplatin|Drug: paclitaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00091039
188027188027Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic CancerCompletedHas ResultsAdenocarcinoma of the Pancreas|Recurrent Pancreatic Cancer|Stage II Pancreatic Cancer|Stage III Pancreatic Cancer|Stage IV Pancreatic CancerBiological: cetuximab|Drug: gemcitabine hydrochloride|Biological: bevacizumab|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00091026
188028188028Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's SarcomaCompletedHas ResultsSarcomaDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00090987
188029188029Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast CancerActive, not recruitingNo Results AvailableBreast CancerProcedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00090974
188030188030S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung CancerTerminatedNo Results AvailableLung Cancer|Pulmonary ComplicationsOther: educational intervention|Other: supervised exercise programhttps://ClinicalTrials.gov/show/NCT00090961
188031188031Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNo Results AvailableLymphomaDrug: cisplatin|Drug: dexamethasone|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00090909
188032188032CP-675,206 (CTLA4-Blocking Monoclonal Antibody) Combined With Dendritic Cell Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed With SurgeryCompletedNo Results AvailableMelanoma (Skin)Biological: maximum tolerated dose of anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibodyhttps://ClinicalTrials.gov/show/NCT00090896
188033188033PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney CancerCompletedNo Results AvailableKidney CancerBiological: PEG-interferon alfa-2b|Biological: sargramostim|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00090870
188034188034Letrozole in Preventing Breast Cancer in Postmenopausal WomenCompletedNo Results AvailableBreast CancerDrug: letrozolehttps://ClinicalTrials.gov/show/NCT00090857
188035188035Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast CancerTerminatedHas ResultsBreast Cancer|Hormone Changes|Drug ToxicityDrug: triptorelinhttps://ClinicalTrials.gov/show/NCT00090844
188036188036Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan DepletionCompletedNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00090831
188037188037Clinical Research Core Dental Screening ProtocolCompletedNo Results AvailableOral Mucosal Diseasehttps://ClinicalTrials.gov/show/NCT00090818
188038188038Nine Month Course of Anti-HIV Medications for People Recently Infected With HIVTerminatedHas ResultsHIV InfectionsDrug: Emtricitabine/ tenofovir disoproxil fumarate|Drug: Lopinavir/Ritonavirhttps://ClinicalTrials.gov/show/NCT00090779
188039188039A Study of Valcyte (Valganciclovir) Syrup Formulation in Pediatric Solid Organ Transplant RecipientsCompletedNo Results AvailableCytomegalovirus InfectionsDrug: valganciclovir [Valcyte]https://ClinicalTrials.gov/show/NCT00090766
188040188040A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal AnemiaCompletedHas ResultsAnemiaDrug: Methoxy Polyethylene Glycol-Epoetin Beta|Drug: Epoetin alfa|Drug: Epoetin beta|Drug: Darbepoetin alfahttps://ClinicalTrials.gov/show/NCT00090753

* Görseller ve İçerik tekif hakkına sahip olabilir